STK11
Serine/threonine-protein kinase STK11
Also known as: LKB1, PJS, STK11_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15831
- Gene
- STK11
- Ensembl
- ENSG00000118046
- Chromosome
- 19
- Canonical length
- 433 aa
- Protein class
- Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Primary cilium,Centrosome,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a serine/threonine kinase that regulates cell polarity and energy metabolism and functions as a tumor suppressor. Mutations in this gene have been associated with the autosomal dominant Peutz-Jeghers syndrome, as well as with skin, pancreatic, and testicular cancers. [provided by RefSeq, May 2022]
Canonical amino-acid sequenceUniProt
433 residues, UniProt reviewed canonical sequence.
>Q15831|STK11
1 MEVVDPQQLG MFTEGELMSV GMDTFIHRID STEVIYQPRR KRAKLIGKYL MGDLLGEGSY
61 GKVKEVLDSE TLCRRAVKIL KKKKLRRIPN GEANVKKEIQ LLRRLRHKNV IQLVDVLYNE
121 EKQKMYMVME YCVCGMQEML DSVPEKRFPV CQAHGYFCQL IDGLEYLHSQ GIVHKDIKPG
181 NLLLTTGGTL KISDLGVAEA LHPFAADDTC RTSQGSPAFQ PPEIANGLDT FSGFKVDIWS
241 AGVTLYNITT GLYPFEGDNI YKLFENIGKG SYAIPGDCGP PLSDLLKGML EYEPAKRFSI
301 RQIRQHSWFR KKHPPAEAPV PIPPSPDTKD RWRSMTVVPY LEDLHGADED EDLFDIEDDI
361 IYTQDFTVPG QVPEEEASHN GQRRGLPKAV CMNGTEAAQL STKSRAEGRA PNPARKACSA
421 SSKIRRLSAC KQQLocalizationUniProt · AlphaFold · HPA
Whether an antibody against STK11 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 106 nTPM
Expression across tissuesHPA
Tissue
- testis: 106 nTPM
- skeletal muscle: 89 nTPM
- cerebellum: 46 nTPM
- spleen: 41 nTPM
- heart muscle: 39 nTPM
- liver: 37 nTPM
Single-cell type
- late spermatids: 622 nCPM
- epicardial cells: 350 nCPM
- late primary spermatocytes: 230 nCPM
- early spermatids: 142 nCPM
- erythrocyte progenitors: 54 nCPM
- megakaryocytes: 50 nCPM
Immune cell
- neutrophil: 9.9 nTPM
- non-classical monocyte: 5.8 nTPM
- intermediate monocyte: 5.5 nTPM
- eosinophil: 3.9 nTPM
- classical monocyte: 3.3 nTPM
- memory B-cell: 2.3 nTPM
Brain region
- choroid plexus: 60 nTPM
- cerebellum: 59 nTPM
- cerebral cortex: 53 nTPM
- midbrain: 50 nTPM
- medulla oblongata: 48 nTPM
- amygdala: 47 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STK11.
Disease | AllUniProt
Conditions STK11 is implicated in, by any mechanism.
- Peutz-Jeghers syndrome (PJS) MIM:175200
- Testicular germ cell tumor (TGCT) MIM:273300
Disease | GeneticClinVar
407 pathogenic / likely-pathogenic of 3,017 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Peutz-Jeghers syndrome
- Hereditary cancer-predisposing syndrome
- Melanoma, cutaneous malignant, susceptibility to, 1
- Germ cell tumor of testis
- Familial pancreatic carcinoma
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 0.99
- gnomAD missense Z
- 1.6
- DepMap mean gene effect
- -0.14
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- activation of protein kinase activity
- anoikis
- autophagy
- axonogenesis
- cellular response to UV-B
- dendrite extension
- DNA damage response
- epithelial cell proliferation involved in prostate gland development
- establishment of cell polarity
- G1 to G0 transition
- glucose homeostasis
- Golgi localization
- intrinsic apoptotic signaling pathway by p53 class mediator
- negative regulation of canonical Wnt signaling pathway
- negative regulation of cell growth
- negative regulation of cell population proliferation
- negative regulation of cold-induced thermogenesis
- negative regulation of epithelial cell proliferation involved in prostate gland development
- negative regulation of TORC1 signaling
- peptidyl-threonine phosphorylation
- positive regulation of autophagy
- positive regulation of axonogenesis
- positive regulation of protein localization to nucleus
- positive regulation of transforming growth factor beta receptor signaling pathway
- positive thymic T cell selection
- protein autophosphorylation
- protein dephosphorylation
- protein localization to nucleus
- protein phosphorylation
- regulation of cell cycle
- regulation of cell growth
- regulation of dendrite morphogenesis
- regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
- regulation of signal transduction by p53 class mediator
- regulation of Wnt signaling pathway
- response to ionizing radiation
- signal transduction
- spermatogenesis
- T cell receptor signaling pathway
- tissue homeostasis
- vasculature development
- positive regulation of vesicle transport along microtubule
Molecular functions
- ATP binding
- LRR domain binding
- magnesium ion binding
- p53 binding
- protein kinase activator activity
- protein serine kinase activity
- protein serine/threonine kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Protein kinase domain
- Serine/threonine-protein kinase, active site
- Protein kinase-like domain superfamily
- Protein kinase, ATP binding site
- Protein kinase domain
- Serine/Threonine kinase LKB1, catalytic domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STK11 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STK11 as an antibody target. Whether an autoantibody or antibody against STK11 could matter depends on whether native STK11 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STK11 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label STK11 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...